Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Altimmune (ALT) Operating Margin (2016 - 2025)

Altimmune has reported Operating Margin over the past 16 years, most recently at 180576.92% for Q4 2025.

  • Quarterly Operating Margin fell 98630308.0% to 180576.92% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 45478.05% through Dec 2025, up 5433195.0% year-over-year, with the annual reading at 45478.05% for FY2025, 5433195.0% up from the prior year.
  • Operating Margin was 180576.92% for Q4 2025 at Altimmune, up from 417180.0% in the prior quarter.
  • Over five years, Operating Margin peaked at 1166880.0% in Q4 2024 and troughed at 1237600.0% in Q3 2022.
  • The 5-year median for Operating Margin is 97243.63% (2023), against an average of 185768.89%.
  • Year-over-year, Operating Margin crashed -121658481bps in 2022 and then soared 125775297bps in 2024.
  • A 5-year view of Operating Margin shows it stood at 731.92% in 2021, then crashed by -12036bps to 88823.08% in 2022, then decreased by -2bps to 90872.97% in 2023, then soared by 1384bps to 1166880.0% in 2024, then tumbled by -85bps to 180576.92% in 2025.
  • Per Business Quant, the three most recent readings for ALT's Operating Margin are 180576.92% (Q4 2025), 417180.0% (Q3 2025), and 458440.0% (Q2 2025).